PDR - Proliferative Diabetic Retinopathy Clinical Trial
Official title:
An Exploratory ITT(Investigator Initiated Study) Study to Evaluate the Preliminary Safety and Efficacy of Single Subretinal Injection of RRG001 at the End of or After Vitrectomy in Subjects With PDR
This study aims to slow down disease progression, reduce postoperative complications and decrease retreatment frequency in subjects with proliferative diabetic retinopathy (PDR) by administering a single subretinal injection of RRG001 gene therapy after vitrectomy.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04692688 -
Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy
|
Phase 2 |